Tag:

meningitis

Latest Headlines

Latest Headlines

Pfizer, Novartis square off for tussle in meningitis vaccine market

Pfizer and Novartis have been racing to get their meningitis B vaccines to market for years. But as of Tuesday, the contest has never been closer, with both companies submitting approval applications to the FDA. Now, it's up to the agency to decide which shot gets the green light first--and first crack at the wide-open patient pool that comes with it.

Pfizer, Novartis race to market with 'breakthrough' meningitis B vaccines

Both Pfizer and Novartis have picked up the FDA's much-coveted breakthrough-therapy designation for their meningitis B vaccines, and now the rivals have chosen the same day to submit their injections for approval, leaving it up to regulators which will hit the market first.

Sanofi looks to make a splash with meningitis booster-shot push

When looking for celebrity spokespeople, pharma companies want someone who can deliver a health message as a peer might. And for Sanofi, which is trying to spread the word about the importance of meningitis booster shots--amid lagging sales of its vaccines for the deadly disease--that person is 12-time Olympic medalist swimmer Dara Torres.

Sanofi hopes to make a splash with new meningitis vax initiative

According to a new survey, more than two in three mothers have little to no knowledge of the CDC's recommendations for preventing meningococcal meningitis. And if you're a meningitis vaccine maker like Sanofi, that's a troubling statistic

Sanofi steps up meningitis marketing amid lagging Menactra sales

Meningitis vaccine maker Sanofi has launched a new initiative that it hopes will increase awareness of the CDC's recommendations for preventing meningococcal meningitis--and give sales a boost in the process.

Novartis' vaccine unit gets a badly needed booster from the U.K.

The U.K.'s Joint Committee on Vaccination and Immunization (JCVI) is revising its stance on Novartis' meningitis B vaccine Bexsero. The jab, originally left off Britain's routine vaccination schedule, has gained the JCVI's nod, supplying a needed boost for the Swiss company's flailing vaccine unit.

Pfizer snags a 'breakthrough' tag for its meningitis vaccine in a race with Novartis

Pfizer picked up the FDA's breakthrough therapy designation for an in-development vaccine against meningococcal disease, a common cause of meningitis, lighting the path for an accelerated approval as the drugmaker looks to expand its vaccine portfolio beyond the blockbuster Prevnar 13.

CDC considers expanding use of Bexsero as meningitis outbreak spreads

Princeton University will not begin to offer Novartis' meningitis B vaccine to Bexsero to students until next week, but health officials are already considering expanding the campaign to another university. An outbreak at the University of California, Santa Barbara, is the cause of the latest concerns.

Princeton weighs emergency vaccine campaign with Novartis' Bexsero shot

Novartis has been wanting to get its meningitis vaccine Bexsero into the U.S. market. Thanks to an outbreak at Princeton University, that's going to happen sooner than the Swiss drugmaker thought. Ahead of FDA approval, in fact.

CDC to import unapproved Novartis vaccine to stem Princeton meningitis outbreak

As a meningitis outbreak has slowly spread across Princeton University over the past 8 months, the case for vaccinating students has grown stronger. The only hitch is that the vaccine, Novartis' Bexsero, has yet to win approval in the U.S. Now, though, health authorities are willing to work around this obstacle.